Neurofilament light as a translational biomarker from preclinical drug discovery to clinical application

insights from industryPhillip MitchellScience Director of Integrated BiologyCharles River Laboratories In this interview, industry expert Phillip Mitchell discusses the role of NfL biomarkers in CNS drug discovery, neurodegenerative disease research, treatment monitoring, neurotoxicity detection, and AI-driven biomarker selection. Can you tell us about your background and current role? My name is Phillip Mitchell, I am… Continue reading Neurofilament light as a translational biomarker from preclinical drug discovery to clinical application